Promega Awarded Key DNA Typing Patent; Powerful DNA Technology Uses Smaller DNA Samples to Solve Crimes

Apr 25, 2001, 01:00 ET from Promega Corporation

    MADISON, Wis., April 25 /PRNewswire/ -- The U.S. Patent and Trademark
 Office issued a key patent to Promega Corporation for its DNA typing
 technology.  Promega, a pioneer in DNA analysis, creates and supplies genetic
 identity tools to criminal justice systems in 90 countries.  Issued on
 April 24th, the patent strengthens the company's human identification patent
 portfolio and enables powerful technologies that require only minute samples
 of genetic materials in order to solve crimes.
     U.S. Patent No. 6,221,598 covers a method for multiplexing certain
 significant DNA loci containing highly variable short tandem repeats (STRs), a
 vital technology used in forensic and paternity testing.  The methodology
 allows crime labs to evaluate multiple loci simultaneously, which means less
 DNA evidence is required to determine a suspect's identity.
     The STR technology is already in use with Promega's recently validated
 PowerPlex(R) 16 system.  This multiplex STR system allows for the simultaneous
 amplification and detection of the 13 loci needed to satisfy the world's major
 investigation agencies, such as the FBI and ENFSI, the European police
 network.  DNA samples of as few as 50 cells -- the equivalent of what would
 remain on a cigarette butt that a suspect has smoked -- are sufficient enough
 for the PowerPlex 16 system to test.   The FBI recently confirmed that the new
 system meets all validation criteria for casework and database uploads to
 CODIS, the national criminal DNA database.
     "The law enforcement community must have advanced technology to meet the
 ever-growing demand for DNA analysis," noted Bill Linton, chairman and CEO of
 Promega.
     "The multiplex technology covered by this new patent is the basis for
 powerful tools for crime labs across the country to accelerate criminal
 investigations."
     Promega, a leader in DNA typing systems since the field was established,
 filed the original parent application in 1994.  The company plans to offer
 multiplexing rights broadly to the genetic identity testing market consisting
 of federal, state, and private crime laboratories across the country.
 
     Promega Corporation is a global leader in providing innovative solutions
 and technical support for the life sciences industry.  The company's
 1,200 products enable scientists worldwide to advance knowledge in genomics,
 proteomics, and cell function research, molecular diagnostics, drug discovery
 and human identification.  Founded in 1978, the company is headquartered in
 Madison, Wis.  Annual sales exceed $100 million.  For more information about
 Promega, visit http://www.promega.com
 
                      MAKE YOUR OPINION COUNT - Click Here
                http://tbutton.prnewswire.com/prn/11690X24624535
 
 

SOURCE Promega Corporation
    MADISON, Wis., April 25 /PRNewswire/ -- The U.S. Patent and Trademark
 Office issued a key patent to Promega Corporation for its DNA typing
 technology.  Promega, a pioneer in DNA analysis, creates and supplies genetic
 identity tools to criminal justice systems in 90 countries.  Issued on
 April 24th, the patent strengthens the company's human identification patent
 portfolio and enables powerful technologies that require only minute samples
 of genetic materials in order to solve crimes.
     U.S. Patent No. 6,221,598 covers a method for multiplexing certain
 significant DNA loci containing highly variable short tandem repeats (STRs), a
 vital technology used in forensic and paternity testing.  The methodology
 allows crime labs to evaluate multiple loci simultaneously, which means less
 DNA evidence is required to determine a suspect's identity.
     The STR technology is already in use with Promega's recently validated
 PowerPlex(R) 16 system.  This multiplex STR system allows for the simultaneous
 amplification and detection of the 13 loci needed to satisfy the world's major
 investigation agencies, such as the FBI and ENFSI, the European police
 network.  DNA samples of as few as 50 cells -- the equivalent of what would
 remain on a cigarette butt that a suspect has smoked -- are sufficient enough
 for the PowerPlex 16 system to test.   The FBI recently confirmed that the new
 system meets all validation criteria for casework and database uploads to
 CODIS, the national criminal DNA database.
     "The law enforcement community must have advanced technology to meet the
 ever-growing demand for DNA analysis," noted Bill Linton, chairman and CEO of
 Promega.
     "The multiplex technology covered by this new patent is the basis for
 powerful tools for crime labs across the country to accelerate criminal
 investigations."
     Promega, a leader in DNA typing systems since the field was established,
 filed the original parent application in 1994.  The company plans to offer
 multiplexing rights broadly to the genetic identity testing market consisting
 of federal, state, and private crime laboratories across the country.
 
     Promega Corporation is a global leader in providing innovative solutions
 and technical support for the life sciences industry.  The company's
 1,200 products enable scientists worldwide to advance knowledge in genomics,
 proteomics, and cell function research, molecular diagnostics, drug discovery
 and human identification.  Founded in 1978, the company is headquartered in
 Madison, Wis.  Annual sales exceed $100 million.  For more information about
 Promega, visit http://www.promega.com
 
                      MAKE YOUR OPINION COUNT - Click Here
                http://tbutton.prnewswire.com/prn/11690X24624535
 
 SOURCE  Promega Corporation